Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (531-540 of 942) with videos related to

Pageof 95
Sort By:
Circulation|October 25, 2000
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudyD A Morrow, E M Antman, A Charlesworth, et al.
Circulation|July 19, 2006
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor TrialDavid A Morrow, James A de Lemos, Marc S Sabatine, et al.
American Heart Journal|April 15, 2018
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialEric J Velazquez, David A Morrow, Adam D DeVore, et al.
Journal of Intensive Care Medicine|March 24, 2021
Trends in Therapy and Outcomes Associated With Respiratory Failure in Patients Admitted to the Cardiac Intensive Care UnitJacob C Jentzer, Carlos L Alviar, P Elliott Miller, et al.
Lancet (London, England)|November 22, 2001
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudyD A Morrow, E M Antman, R P Giugliano, et al.
Diabetes Care|November 30, 2012
Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover studyJulio Rosenstock, Richard M Bergenstal, Thomas C Blevins, et al.
European Journal of Heart Failure|February 19, 2019
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGADDalia L Rotstein, Mark S Freedman, Andrea Konig, et al.
Journal of the American College of Cardiology|January 5, 2005
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudyHisham Dokainish, Manu Pillai, Sabina A Murphy, et al.
The New England Journal of Medicine|October 6, 2001
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromesJ A de Lemos, D A Morrow, J H Bentley, et al.
Pageof 95

Showing results (531-540 of 942) with videos related to

Sort By:
Pageof 95
Circulation|October 25, 2000
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudyD A Morrow, E M Antman, A Charlesworth, et al.
Circulation|July 19, 2006
Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor TrialDavid A Morrow, James A de Lemos, Marc S Sabatine, et al.
American Heart Journal|April 15, 2018
Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trialEric J Velazquez, David A Morrow, Adam D DeVore, et al.
Journal of Intensive Care Medicine|March 24, 2021
Trends in Therapy and Outcomes Associated With Respiratory Failure in Patients Admitted to the Cardiac Intensive Care UnitJacob C Jentzer, Carlos L Alviar, P Elliott Miller, et al.
Lancet (London, England)|November 22, 2001
A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II substudyD A Morrow, E M Antman, R P Giugliano, et al.
Diabetes Care|November 30, 2012
Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover studyJulio Rosenstock, Richard M Bergenstal, Thomas C Blevins, et al.
European Journal of Heart Failure|February 19, 2019
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 5, 2024
Investigation of health care use and a possible prodrome before the first attack in NMOSD and MOGADDalia L Rotstein, Mark S Freedman, Andrea Konig, et al.
Journal of the American College of Cardiology|January 5, 2005
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudyHisham Dokainish, Manu Pillai, Sabina A Murphy, et al.
The New England Journal of Medicine|October 6, 2001
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromesJ A de Lemos, D A Morrow, J H Bentley, et al.
Pageof 95